DAFNA Capital Management »

Kardigan Ord shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Kardigan Ord shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Kardigan Ord

Tip: Access up to 7 years of quarterly data

All positions including Kardigan Ord held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kardigan Ord by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $119k 5.0k 23.85

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Kardigan Ord

SCHF
FMR
Perceptive Advisors
Capital Research Global Investors
Jpmorgan Chase & Co
Alliancebernstein
Liberty Mutual Group Asset Management
Jennison Associates
Paradigm Biocapital Advisors
Jupiter Topco
Massachusetts Financial Services
Goldman Sachs Group
Deep Track Capital
Woodline Partners
Franklin Resources

View all funds holding Kardigan Ord